Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

138 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Retraction: characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma.
Stevenson M, Mostertz W, Acharya CR, Kim W, Walters K, Barry W, Higgins K, Tuchman SA, Crawford J, Vlahovic G, Ready N, Onaitis M, Potti A. Stevenson M, et al. Among authors: Potti A. Clin Cancer Res. 2012 Mar 15;18(6):1818. doi: 10.1158/1078-0432.CCR-12-0337. Epub 2012 Feb 21. Clin Cancer Res. 2012. PMID: 22355011 Free article. No abstract available.
Genomic and molecular profiling predicts response to temozolomide in melanoma.
Augustine CK, Yoo JS, Potti A, Yoshimoto Y, Zipfel PA, Friedman HS, Nevins JR, Ali-Osman F, Tyler DS. Augustine CK, et al. Clin Cancer Res. 2009 Jan 15;15(2):502-10. doi: 10.1158/1078-0432.CCR-08-1916. Clin Cancer Res. 2009. PMID: 19147755
Toward the individualization of lung cancer therapy.
Anguiano A, Nevins JR, Potti A. Anguiano A, et al. Cancer. 2008 Oct 1;113(7 Suppl):1760-7. doi: 10.1002/cncr.23644. Cancer. 2008. PMID: 18800387
The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design.
Jones LW, Eves ND, Kraus WE, Potti A, Crawford J, Blumenthal JA, Peterson BL, Douglas PS. Jones LW, et al. BMC Cancer. 2010 Apr 21;10:155. doi: 10.1186/1471-2407-10-155. BMC Cancer. 2010. PMID: 20409311 Free PMC article. Clinical Trial.
Tyrosine kinase inhibitors in renal cell carcinoma.
Potti A, George DJ. Potti A, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6371S-6S. doi: 10.1158/1078-0432.CCR-050014. Clin Cancer Res. 2004. PMID: 15448033 Review.
Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma.
Anguiano A, Tuchman SA, Acharya C, Salter K, Gasparetto C, Zhan F, Dhodapkar M, Nevins J, Barlogie B, Shaughnessy JD Jr, Potti A. Anguiano A, et al. J Clin Oncol. 2009 Sep 1;27(25):4197-203. doi: 10.1200/JCO.2008.19.1916. Epub 2009 Jul 27. J Clin Oncol. 2009. PMID: 19636021 Free PMC article.
Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.
Hsu DS, Balakumaran BS, Acharya CR, Vlahovic V, Walters KS, Garman K, Anders C, Riedel RF, Lancaster J, Harpole D, Dressman HK, Nevins JR, Febbo PG, Potti A. Hsu DS, et al. J Clin Oncol. 2007 Oct 1;25(28):4350-7. doi: 10.1200/JCO.2007.11.0593. J Clin Oncol. 2007. PMID: 17906199 Retracted.
138 results
Jump to page
Feedback